Sanchez-de la Rosa, Rainel; Sabater, Eliazar; Casado, … - In: Health Economics Review 3 (2013) 13, pp. 1-5
Background: Fingolimod is an innovative drug with a significant budget impact in the treatment of MS in Spain. The aim of this study was to calculate the direct cost comparison of glatiramer acetate and fingolimod for the treatment of patients with relapsing-remitting multiple sclerosis (RRMS)...